Selegiline Alleviates the Depressive-Like Behaviors of Methamphetamine Withdrawal Syndrome Through Modulating Mitochondrial Function and Energy Hemostasis

Background: Methamphetamine (METH) is considered the second most commonly abused drug in the world. There is limited or no evidence concerning the effective treatment of METH withdrawal symptoms, such as depression and anxiety. Mode of action of selegiline (increase of the brain neurotransmitter act...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Mir-Jamal Hosseini, Sima Askari Sadat-Mahaleh, Hamed Ghavimi
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Tabriz University of Medical Sciences 2022-04-01
Schriftenreihe:	Pharmaceutical Sciences
Schlagworte:	selegiline methamphetamine depression mitochondrion oxidative stress fluoxetine
Online-Zugang:	https://ps.tbzmed.ac.ir/PDF/ps-28-251.pdf
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!